🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Atrial Fibrillation (Prevention of Stroke)

Early Treatment of Atrial Fibrillation for Stroke Prevention Trial in Acute STROKE NCT05293080Phase 31 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf · Tests: Medical or interventional therapy for rhythm control in atrial fibrillation (antiarrhythmic drugs, ablation, electric c… The Southern-Norway Post-Stroke Atrial Fibrillation Study NCT07407790NA1 site📍 Kristiansand Sorlandet Hospital HF · Tests: Patch ECG, Standard Care (in control arm) BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis NCT07237308Phase 41 site📍 Seoul Yonsei University · Tests: Apixaban, Clopidogrel Left Atrial Strain and Cryptogenic Stroke NCT07224178n/a1 site📍 Pittsburgh University of Pittsburgh Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation NCT05723926NA21 sites📍 Rockford📍 Boston📍 New York Javelin Medical · Tests: Vine Filter Accuracy of LAA Occluder Size Selection: CT vs. DSA During Combined AF Ablation and LAA Occlusion NCT06455644NA5 sites📍 Foshan📍 Foshan📍 Meizhou First Affiliated Hospital of Shantou University Medical Col… · Tests: CT group, DSA group Stroke Risk Assessment and Markers of Blood Clotting in Patients With Newly Diagnosed Non-valvular Atrial Fibrillation (NVAF), Who Have Not Received Oral Anticoagulation Therapy (OAC-therapy) Prior to Inclusion NCT06949319n/a1 site📍 Esbjerg Nedim Tojaga Digital Screening for Atrial Fibrillation to Prevent Stroke NCT07684053NA1 site📍 Innsbruck Medical University Innsbruck · Tests: Smartphone-based digital atrial fibrillation screening and management pathway Left Atrial Appendage Closure as Secondary Prevention of Atrial Fibrillation-related Embolic Events NCT04559243n/a5 sites📍 Jinan📍 Shanghai📍 Mianyang Lifetech Scientific (Shenzhen) Co., Ltd. · Tests: Transthoracic Echocardiography Comparison of Different Pulsed Field Ablation Catheters in Atrial Fibrillation NCT07036965NA1 site📍 Hangzhou Hangzhou Dinova EP Technology Co., Ltd · Tests: CardiPulse, FaraPulse Smartwatches for Detection of Atrial Fibrillation (AFib) in Secondary Prevention of Cryptogenic Stroke NCT06005233NA1 site📍 Munich Technical University of Munich · Tests: Smartwatch Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress NCT03968393Phase 4105 sites📍 Los Angeles📍 Houston📍 Coronel Suárez Population Health Research Institute · Tests: Non-vitamin K oral anticoagulant (NOAC) COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation NCT04642430Phase 48 sites📍 Victoria📍 Halifax📍 Kingston Ottawa Hospital Research Institute · Tests: Apixaban, Rivaroxaban RAPID AFib Decision Aid for Stroke Prevention in Atrial Fibrillation NCT05900414NA2 sites📍 Calgary📍 Calgary University of Calgary · Tests: Electronic patient decision aid, Information
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy